Traws Pharma, Inc. (TRAW) stock
TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.25−0.03 (-11.87%)
Close on Nov 13, 2026Market cap $3.86MP/E –Yield –
Traws Pharma total assets
Total assets on the balance sheet at the end of each period.
Traws Pharma's total assets was $11.47M at Jun 30, 2026. For fiscal 2025 it was $10.62M, down 57.5% from the year before. Over ten years it grew -7.6% a year on average. The highest annual figure on record is $105.15M in fiscal 2013.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.62M | -57.5% |
| FY2024 | Dec 31, 2024 | $24.96M | +10.0% |
| FY2023 | Dec 31, 2023 | $22.68M | -42.4% |
| FY2022 | Dec 31, 2022 | $39.37M | -29.0% |
| FY2021 | Dec 31, 2021 | $55.48M | +177.6% |
| FY2020 | Dec 31, 2020 | $19.99M | -15.6% |
| FY2019 | Dec 31, 2019 | $23.67M | +32.1% |
| FY2018 | Dec 31, 2018 | $17.92M | +260.0% |
| FY2017 | Dec 31, 2017 | $4.98M | -78.6% |
| FY2016 | Dec 31, 2016 | $23.23M | -0.9% |
| FY2015 | Dec 31, 2015 | $23.45M | -50.5% |
| FY2014 | Dec 31, 2014 | $47.34M | -55.0% |
| FY2013 | Dec 31, 2013 | $105.15M | +25.4% |
| FY2012 | Dec 31, 2012 | $83.85M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $11.47M | -26.6% |
| Q1 FY2026 | Mar 31, 2026 | $8.16M | -57.2% |
| Q4 FY2025 | Dec 31, 2025 | $10.62M | -57.5% |
| Q3 FY2025 | Sep 30, 2025 | $12.44M | +39.2% |
| Q2 FY2025 | Jun 30, 2025 | $15.62M | -16.4% |
| Q1 FY2025 | Mar 31, 2025 | $19.06M | +4.9% |
| Q4 FY2024 | Dec 31, 2024 | $24.96M | +10.0% |
| Q3 FY2024 | Sep 30, 2024 | $8.94M | -67.0% |
| Q2 FY2024 | Jun 30, 2024 | $18.69M | -38.7% |
| Q1 FY2024 | Mar 31, 2024 | $18.17M | -48.2% |
| Q4 FY2023 | Dec 31, 2023 | $22.68M | -42.4% |
| Q3 FY2023 | Sep 30, 2023 | $27.04M | -38.2% |
| Q2 FY2023 | Jun 30, 2023 | $30.47M | -36.6% |
| Q1 FY2023 | Mar 31, 2023 | $35.06M | -31.8% |
| Q4 FY2022 | Dec 31, 2022 | $39.37M | -29.0% |
| Q3 FY2022 | Sep 30, 2022 | $43.78M | -27.0% |
| Q2 FY2022 | Jun 30, 2022 | $48.07M | +8.3% |
| Q1 FY2022 | Mar 31, 2022 | $51.42M | +5.3% |
| Q4 FY2021 | Dec 31, 2021 | $55.48M | +177.6% |
| Q3 FY2021 | Sep 30, 2021 | $59.99M | +138.0% |
| Q2 FY2021 | Jun 30, 2021 | $44.38M | +57.4% |
| Q1 FY2021 | Mar 31, 2021 | $48.85M | +52.3% |
| Q4 FY2020 | Dec 31, 2020 | $19.99M | -15.6% |
| Q3 FY2020 | Sep 30, 2020 | $25.21M | +319.8% |
| Q2 FY2020 | Jun 30, 2020 | $28.20M | +228.7% |
| Q1 FY2020 | Mar 31, 2020 | $32.07M | +182.8% |
| Q4 FY2019 | Dec 31, 2019 | $23.67M | +32.1% |
| Q3 FY2019 | Sep 30, 2019 | $6.01M | -74.0% |
| Q2 FY2019 | Jun 30, 2019 | $8.58M | -71.6% |
| Q1 FY2019 | Mar 31, 2019 | $11.34M | +31.6% |
| Q4 FY2018 | Dec 31, 2018 | $17.92M | +260.0% |
| Q3 FY2018 | Sep 30, 2018 | $23.14M | +162.8% |
| Q2 FY2018 | Jun 30, 2018 | $30.20M | +87.6% |
| Q1 FY2018 | Mar 31, 2018 | $8.62M | -48.0% |
| Q4 FY2017 | Dec 31, 2017 | $4.98M | -78.6% |
| Q3 FY2017 | Sep 30, 2017 | $8.80M | -68.7% |
| Q2 FY2017 | Jun 30, 2017 | $16.10M | – |
| Q1 FY2017 | Mar 31, 2017 | $16.55M | – |
| Q4 FY2016 | Dec 31, 2016 | $23.23M | – |
| Q3 FY2016 | Sep 30, 2016 | $28.09M | – |
See a number that looks wrong?